Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05736146 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Validating Gulf War Illness Blood Biomarkers

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 24, 2025 (before its estimated December 1, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Jun 1, 2025 to Dec 1, 2025
    • Site contacts updated at 3 of 3 sites
    v5
  2. Primary completion date: Sep 2024 to Jun 1, 2025
    • Study completion date: Sep 2024 to Mar 1, 2026
    • Site contacts updated at 3 of 3 sites
    v4
  3. Site contacts updated at 1 of 3 sitesv3
  4. Study description shortened, about 11 wordsv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The investigators goals are to identify blood lipids/metabolites that correlate with cognitive decline in the presence of the APOE ε4 allele among veterans with GWI. To determine the effect of dietary, medical and biological factors that influence lipid and metabolites in blood from GW veterans. To identify blood lipid/metabolite profiles that correlate with bioenergetics deficits and glial activation in the brains of GWI. To validate blood biomarker signatures of GWI using APOE genotyping and blood lipids/metabolites that correlate with the CNS dysfunction in GWI.
Trial Details
NCT Number NCT05736146
Lead Sponsor Roskamp Institute Inc.
Collaborators: Boston University, Palo Alto Veterans Institute for Research, United States Department of Defense
Conditions
(from sponsor)		 Gulf War Syndrome, Gulf War Illness
Related terms Persian Gulf Syndrome
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov